Acute Traumatic Ischemia Hyperbaric Evaluation and Treatment
Introduction
Trauma to a limb causes direct tissue damage and local hypoxia secondary to edema, resulting in acute traumatic peripheral ischemia. The severity of trauma ranges from mild to irreversible and may involve major blood vessels and nerve injuries. Severe injuries may necessitate amputation. Vascular repair and reimplantation may be required to preserve limb viability. Examples of trauma include crush and thermal injuries.
Even in the absence of a major vascular insult, tissue damage can produce edema, which exacerbates hypoxia and further increases edema. This pathophysiologic cycle may precipitate compartment syndrome within noncompliant muscle compartments, representing a surgical emergency to salvage the limb. Threatened flaps also constitute acute traumatic peripheral ischemia, for which hyperbaric oxygen therapy (HBOT) has demonstrated improvement in ischemic conditions.[1]
Surgical intervention and HBOT are complementary, not exclusionary, modalities, and should be employed in coordination to optimize patient outcomes. Management of acute traumatic peripheral ischemia is included among the 15 approved indications for HBOT by the Undersea and Hyperbaric Medical Society.[2] The procedure is also approved by the Centers for Medicare and Medicaid Services.
The organization states that acute traumatic peripheral ischemia or crush injuries, particularly after surgical reattachment of severed limbs, represent a scenario in which HBOT serves as a valuable, supplementary treatment. HBOT may be used in combination with established therapeutic measures when patients are at risk of functional loss, limb loss, or mortality. In addition to numerous case studies and reports, results from 2 randomized controlled studies conducted nearly 20 years apart showed that incorporating HBOT into standard surgical management reduces the incidence of complications, including amputation, additional surgical procedures, and tissue necrosis.[3][4]
Anatomy and Physiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
After an acute traumatic limb injury, vascular damage produces bleeding into surrounding tissues, with subsequent coagulation and stasis in the vessels. Cellular hypoxia develops, impairing the ability to maintain adequate intracellular water and meet metabolic demands. The resulting edema increases tissue pressure, further exacerbating ischemia and hypoxia, leading to additional cell death and extravascular fluid accumulation. Restoration of blood flow precipitates ischemia-reperfusion injury. Endothelial injury permits fluid extravasation, edema formation, and progressive obstruction of blood flow by neutrophils adhering to the damaged vessel wall.
HBOT mitigates these acute cellular changes; vasoconstriction reduces blood and plasma inflow to the injured region. However, elevated plasma oxygen concentration produces a net increase in oxygen delivery. Reduced edema improves oxygen diffusion distance. HBOT also decreases neutrophil adhesion to the injured endothelium, attenuating ischemia-reperfusion injury.[5]
Indications
Emergency surgical treatments, including revascularization and fracture stabilization, should precede consideration of HBOT. In less urgent cases, HBOT may assist the surgeon in distinguishing viable from nonviable tissue, thereby minimizing tissue loss and reducing the risk of amputation. The decision to initiate HBOT and determine treatment frequency requires close collaboration with the surgeon. Treatment should be guided by the type and severity of injury, as well as patient-specific host factors.
Using an objective grading system, such as the Gustilo open-fracture crush injury classification, combined with a host factor function score incorporating age, smoking status, steroid use, ambulation status, and cardiovascular and renal function, improves patient selection and treatment planning. Even milder injuries in compromised hosts may benefit from HBOT as an adjuvant therapy. Utilization review of HBOT constitutes an important component of clinical care. Review is most effective when conducted collaboratively by surgical and hyperbaric teams after a predetermined number of HBOT sessions.[6][7]
Contraindications
No direct contraindications to HBOT exist in acute traumatic peripheral ischemia unless therapy delays emergent, limb-saving procedures, such as revascularization or fasciotomy for established compartment syndrome. Absolute contraindications are rare and include unrelieved tension pneumothorax.
Equipment
A pressure vessel and 100% oxygen deliver the therapeutic effects of HBOT to the body. There are two types of pressure vessels: monoplace and multiplace chambers. Monoplace chambers typically accommodate a single patient and consist of a transparent acrylic tube with access through a metal door at one end. In monoplace chambers, the chamber is pressurized with 100% oxygen, which the patient breathes directly. Some monoplace chambers include a separate breathing mask to provide air during prescribed air breaks. Equipment such as ventilators, infusion pumps, and physiologic monitoring devices can be integrated to support high-acuity care. Monoplace chambers may be installed in a standard hospital room and connected to the hospital’s oxygen and air supply.
Multiplace chambers are constructed from steel with acrylic viewing ports and can accommodate 2 to 20 patients. These chambers are pressurized with air, while patients breathe oxygen through a tight-fitting mask or a hood sealed around the neck with a rubber neck dam. Patients breathe the chamber air during air breaks. Multiplace chambers are typically large complexes equipped with compressors, reserve air, and oxygen tanks.
Both monoplace and multiplace chambers require specialized manufacturing and installation in accordance with fire protection codes, such as the National Fire Protection Association (NFPA) 99 in the United States (US). Facility accreditation for hyperbaric programs is recommended and is available through the Undersea and Hyperbaric Medical Society in the US and select international locations. Transcutaneous oximetry can measure tissue oxygenation during ambient air exposure and HBOT. A tissue oxygen level exceeding 200 mm Hg during treatment demonstrates a positive predictive value of 0.88 for wound healing.
Personnel
For monoplace chambers, a single specially trained outside attendant may conduct and supervise up to 2 simultaneous HBOT sessions and must remain in continuous attendance outside the chambers. Multiplace chamber operations require both outside and inside specialty-trained attendants. Inside attendants breathe compressed chamber air and are at risk for decompression illness, similar to scuba divers. Strict safety protocols and procedures are required to minimize this risk. An outside chamber operator pressurizes the chamber and maintains constant communication with inside attendants.
A safety director is responsible for the maintenance and safe operation of the hyperbaric facility. A specialty-trained hyperbaric physician prescribes and supervises the pressure, duration, and gas composition of HBOT and examines patients before and after each session. Specialty-trained hyperbaric clinicians and nurses provide wound care, administer medications, and educate patients and families.[8]
Preparation
Safety procedures are required to minimize the introduction of static electricity, fuel, and ignition sources into the hyperbaric environment, thereby reducing fire risk. All personnel inside the chamber must wear cotton or cotton-blend sheets and scrubs. Oily substances and alcohol are prohibited, and ignition sources are not permitted. Myringotomy tubes may be necessary in rare instances where patients have difficulty equalizing middle-ear pressure during compression.
Dressing changes and wound debridement may be required prior to chamber entry, depending on the patient’s injury. Patients requiring monitoring during HBOT must have appropriate sensors applied and connected to pass-through connectors in the chamber hull. Patients requiring medications or infusions may need preparation for specialized infusion pumps. Communication between the primary surgical service and the hyperbaric medical team is essential to ensure safe and effective treatment.
Technique or Treatment
The attending hyperbaric medicine specialist prescribes the duration, pressure, and breathing gas for each patient on the treatment table. In multiplace chambers, the specialist also plans the decompression gas profile for inside attendants. Standard treatment tables for acute traumatic peripheral ischemia include 2 atmospheres absolute (ATA) for 2 hours or 2.4 ATA for 90 minutes. The number of treatments varies depending on the injury type.
A single treatment may suffice to prevent ischemia-reperfusion injury. Crush injuries often require a more intensive schedule of 8 treatments: 1 treatment 3 times a day for 2 days, followed by 2 treatments per day for 2 days, and then 1 treatment per day for an additional 2 days. Impending compartment syndrome is generally managed with 3 treatments: 2 on the first day and 1 on the second day.
Established compartment syndrome requires fasciotomy. However, HBOT remains beneficial postoperatively to address residual tissue ischemia, massive swelling, or nerve injury. Postfasciotomy HBOT may require twice-daily sessions for up to 7 days. Delayed HBOT during the healing process may necessitate additional treatments, depending on wound extent and patient comorbidities.
Complications
HBOT is generally well tolerated. Occasionally, patients with difficulty equalizing middle-ear pressure develop barotrauma of the ears. Management usually involves nasal decongestants, and myringotomy tube placement by an otolaryngologist is rarely required. Pulmonary barotrauma is very uncommon. However, the possibility should be considered if patients develop chest pain during ascent.
Pulmonary and cerebral oxygen toxicity is typically not a concern with the relatively short exposures used for acute traumatic peripheral ischemia, but remains a potential risk. Neurologic oxygen toxicity may result in seizures. Convulsions may be prevented with antiepileptic medications or managed during the episode with benzodiazepines. Reducing treatment depth or oxygen concentration usually resolves these episodes. Introducing a 5-minute air break during treatment further minimizes the risk of oxygen-induced seizures.[9]
Changes in eye refraction generally occur only after prolonged HBOT courses of 40 to 60 sessions and are often reversible. Blood glucose levels may decrease during or after treatment in patients with diabetes, necessitating careful monitoring.[10] Individuals with poorly controlled hypertension also require monitoring and appropriate management during HBOT sessions.[11]
Clinical Significance
Acute traumatic peripheral ischemia can be devastating, potentially resulting in permanent loss of limb or function. The cost of amputation, including rehabilitation and loss of productivity, substantially exceeds the cost of limb salvage and reconstruction, even when HBOT is included, which accounts for approximately 10% of the total expense.[12] HBOT represents an often-overlooked adjunct to surgical management. This intervention interrupts the cycle of edema, ischemia, and hypoxia and mitigates the harmful effects of ischemia-reperfusion injury. Despite its benefits, HBOT is often reserved for treating late complications rather than being applied early, when it is most effective at reducing tissue loss.[13][14][15][16]
Enhancing Healthcare Team Outcomes
The management of acute traumatic peripheral ischemia is complex and challenging. Trauma surgeons and orthopedic specialists direct care, while additional healthcare team members provide expertise to enhance patient outcomes. The Undersea and Hyperbaric Medical Society has proposed a treatment algorithm to identify patients most likely to benefit from HBOT. The algorithm incorporates trauma type and severity, based on the Gustilo classification, as well as patient host factors that may influence therapeutic decisions. Optimal treatment planning for severe traumatic injuries relies on interprofessional collaboration.
Nursing, Allied Health, and Interprofessional Team Interventions
HBOT-trained nurses are essential members of the healthcare team for both monoplace and multiplace chamber operations. Responsibilities include patient care tasks, such as medication administration, blood glucose monitoring, and wound dressing. Multiplace chambers allow nurses to attend to patients within the chamber. In contrast, monoplace chambers position the patient inside, with the technologist supervising from outside. Certified hyperbaric technicians prepare and maintain the technical components of the hyperbaric program to ensure safety and operate the chambers during treatments.
Nursing, Allied Health, and Interprofessional Team Monitoring
Hyperbaric nurses and technicians monitor patients during HBOT by direct visual observation and verbal communication or by cameras and display screens. Vital signs are measured with appropriate sensors connected via specialized pass-throughs in the chamber hulls.
References
Zamboni WA, Roth AC, Russell RC, Smoot EC. The effect of hyperbaric oxygen on reperfusion of ischemic axial skin flaps: a laser Doppler analysis. Annals of plastic surgery. 1992 Apr:28(4):339-41 [PubMed PMID: 1596067]
Level 3 (low-level) evidenceStrauss MB. The role of hyperbaric oxygen for acute traumatic ischemias. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2022 Second Quarter:49(2):233-248 [PubMed PMID: 35580490]
Bouachour G, Cronier P, Gouello JP, Toulemonde JL, Talha A, Alquier P. Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. The Journal of trauma. 1996 Aug:41(2):333-9 [PubMed PMID: 8760546]
Level 1 (high-level) evidenceMillar IL, Lind FG, Jansson KÅ, Hájek M, Smart DR, Fernandes TD, McGinnes RA, Williamson OD, Miller RK, Martin CA, Gabbe BJ, Myles PS, Cameron PA, HOLLT investigator group. Hyperbaric Oxygen for Lower Limb Trauma (HOLLT): an international multi-centre randomised clinical trial. Diving and hyperbaric medicine. 2022 Sep 30:52(3):164-174. doi: 10.28920/dhm52.3.164-174. Epub [PubMed PMID: 36100927]
Level 1 (high-level) evidenceBuras JA, Stahl GL, Svoboda KK, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. American journal of physiology. Cell physiology. 2000 Feb:278(2):C292-302 [PubMed PMID: 10666024]
Level 3 (low-level) evidenceLöndahl M, Boulton AJM. Hyperbaric oxygen therapy in diabetic foot ulceration: Useless or useful? A battle. Diabetes/metabolism research and reviews. 2020 Mar:36 Suppl 1():e3233. doi: 10.1002/dmrr.3233. Epub 2020 Jan 11 [PubMed PMID: 31927787]
Moghadam N, Hieda M, Ramey L, Levine BD, Guilliod R. Hyperbaric Oxygen Therapy in Sports Musculoskeletal Injuries. Medicine and science in sports and exercise. 2020 Jun:52(6):1420-1426. doi: 10.1249/MSS.0000000000002257. Epub [PubMed PMID: 31876671]
Strauss MB, Bryant BJ, Hart GB. Transcutaneous oxygen measurements under hyperbaric oxygen conditions as a predictor for healing of problem wounds. Foot & ankle international. 2002 Oct:23(10):933-7 [PubMed PMID: 12398146]
Level 2 (mid-level) evidenceCosta DA, Ganilha JS, Barata PC, Guerreiro FG. Seizure frequency in more than 180,000 treatment sessions with hyperbaric oxygen therapy - a single centre 20-year analysis. Diving and hyperbaric medicine. 2019 Sep 30:49(3):167-174. doi: 10.28920/dhm49.3.167-174. Epub [PubMed PMID: 31523791]
Baitule S, Patel AH, Murthy N, Sankar S, Kyrou I, Ali A, Randeva HS, Robbins T. A Systematic Review to Assess the Impact of Hyperbaric Oxygen Therapy on Glycaemia in People with Diabetes Mellitus. Medicina (Kaunas, Lithuania). 2021 Oct 19:57(10):. doi: 10.3390/medicina57101134. Epub 2021 Oct 19 [PubMed PMID: 34684171]
Level 1 (high-level) evidenceSchiavo S, Djaiani C, DeBacker J, Albertini L, Santa Mina D, Buryk-Iggers S, De Moraes MV, Kanj M, Katznelson R. Magnitude and Clinical Predictors of Blood Pressure Changes in Patients Undergoing Hyperbaric Oxygen Therapy: A Retrospective Study. International journal of environmental research and public health. 2020 Oct 19:17(20):. doi: 10.3390/ijerph17207586. Epub 2020 Oct 19 [PubMed PMID: 33086495]
Level 2 (mid-level) evidenceMacKenzie EJ, Jones AS, Bosse MJ, Castillo RC, Pollak AN, Webb LX, Swiontkowski MF, Kellam JF, Smith DG, Sanders RW, Jones AL, Starr AJ, McAndrew MP, Patterson BM, Burgess AR. Health-care costs associated with amputation or reconstruction of a limb-threatening injury. The Journal of bone and joint surgery. American volume. 2007 Aug:89(8):1685-92 [PubMed PMID: 17671005]
Garcia-Covarrubias L, McSwain NE Jr, Van Meter K, Bell RM. Adjuvant hyperbaric oxygen therapy in the management of crush injury and traumatic ischemia: an evidence-based approach. The American surgeon. 2005 Feb:71(2):144-51 [PubMed PMID: 16022014]
Level 2 (mid-level) evidenceMyers RA. Hyperbaric oxygen therapy for trauma: crush injury, compartment syndrome, and other acute traumatic peripheral ischemias. International anesthesiology clinics. 2000 Winter:38(1):139-51 [PubMed PMID: 10723673]
Nakamura H, Makiguchi T, Atomura D, Yamatsu Y, Shirabe K, Yokoo S. Changes in Skin Perfusion Pressure After Hyperbaric Oxygen Therapy Following Revascularization in Patients With Critical Limb Ischemia: A Preliminary Study. The international journal of lower extremity wounds. 2020 Mar:19(1):57-62. doi: 10.1177/1534734619868925. Epub 2019 Sep 3 [PubMed PMID: 31478408]
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS). Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2019 Jul:58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8 [PubMed PMID: 31182334]